Form 4 Tracker
Liisa Ann Bayko

Chief Financial Officer · 1 filing · Latest: Jul 20, 2026

Kalaris Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing